Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check out the presentation on their website if you haven’t. Very promising results from their technologies and the potential merger partner also has interesting tech. I am thrilled that all their eggs are not in one basket although everything they are working on looks solid.
From what I can tell, the overall goal is to turn the combined business into a large biotech or sell it off to a large bio. Management in these companies appear to have the contacts to go either direction. The long term potential is just too great to sell at 30-50% profits for me so staying the course.
Merger news likely coming EOD or early next week.
Big news must be coming this the second time this week that big buyers started running it up, and analyst ladenburg thalmann upgraded it with a two dollars PT just last week, do you think they just might know something.
$HJLIW is a huge opportunity here. I think that’s where the big money will be made
And the Aug 10 statement regarding Nasdaq compliance seems to tie together so I think the plan is to merge with price skyrocketing instead of needing to r/s to remain compliant. Just unsure what the 60/40 split will mean and what the pps will look like
The merger news will hit right around the timeframe for positive product trials so dual catalyst. Looking forward to the ride on this one, and loading when I can
Their schedule clearly states 'sign definitive merger agreement' Q3
agreed. HJLI appears to be holding strong and found a good base. Now we work on going back up with some more news!
Agree.. if they stick to the schedule on their website, there will be plenty of news coming in the next quarters and it should be quite positive. If it drops before then I will load more. I really like what this company is doing.
HJLI UP 6% ..Looking at the chart, It would not take much News / PR to move this to .61 ish - .65 ish from current .44 ..Higher with strong News
Right this min. it is close to re-testing, and maybe set yet another New, HOD
UP 6% on Heavy volume second only to Tuesdays
High Relative Volume Stock - Bullish !
Float 37 Mil is not so low it moves so fast a person can miss it, but not large enough to move slow.. Almost perfect float!
$HJLI
Remember, there is no Merger. An intention to merge is not a merger agreement.
In the pink sheets, "announcements" like this are used to deceive pink sheet investors into assuming it is a merger agreement, and 90% of the time, this works, as it did here.
This is similar to a situation where a company says they are testing to then submit for FDA approval, then thinking that this means the product will be approved.
They need to agree to merger before board and shareholder approval. Consummation of merger Q4 assuming it moves forward but right now no guarantee on a definitive agreement. Shareholder split is looking like 60/40 and not in favor of HJLI. I see this trending lower in the short term so I am holding and will look to further cost down pps.
Remember Merger is coming.
Hancock Jaffe Announces Intention to Merge with Catheter Precision.
Catheter Precision has developed a software imaging system called VIVO™, an initial version of which is FDA cleared and CE marked, and that produces a 3-D virtual image of the heart on a computer monitor for the purpose of accurately identifying and targeting the anatomical location of ventricular arrhythmias for catheter ablation therapy. Ventricular arrhythmias are commonly associated with sudden cardiac death, which accounts for approximately 325,000 fatalities in the U.S. each year.
https://finance.yahoo.com/news/hancock-jaffe-announces-intention-merge-123000205.html
There are many that who have been trading for a long time that would agree with that, but only half of that, and do believe MM manipulation is present at certain times, and has changed over time with these days algo trading programs, taking advantage of retail traders trends to make a buck, which at times could possibly be interfering with what should be a stocks real movements, and many also believe when there is toxic note stock converting and than diluting happening, they tend to take up more interest on the side of shorters.
* * $HJLI Video Chart 08-25-2020 * *
Link to Video - click here to watch the technical chart video
THIS LOOKS REALLY STRONG.
David Jenkins, Catheter Precision's Chairman stated, "We are extremely impressed with Hancock Jaffe's early clinical successes and believe that its products have enormous potential. Our goal is to use the public company platform to focus on cardiovascular devices as our core competency, with the possibility of expanding into other areas as we grow the company."
https://ir.hancockjaffe.com/press-releases/detail/66/hancock-jaffe-announces-intention-to-merge-with-catheter
Should be any day. There is a 30-60 day period of exclusivity to finalize formalities - - “The parties have entered into a period of exclusivity in order to negotiate the proposed transaction in good faith.”
https://ir.hancockjaffe.com/press-releases/detail/66/hancock-jaffe-announces-intention-to-merge-with-catheter
“David Jenkins, Catheter Precision's Chairman stated, "We are extremely impressed with Hancock Jaffe's early clinical successes and believe that its products have enormous potential. Our goal is to use the public company platform to focus on cardiovascular devices as our core competency, with the possibility of expanding into other areas as we grow the company."
HJLI Receives Permission to Proceed with First-in-Human CoreoGraft Study
https://www.biospace.com/article/releases/hancock-jaffe-laboratories-company-update/
-“two CoreoGraft surgeries per week, once patients are enrolled in the study. Following patient enrollment, the CoreoGraft surgeries will likely be completed over a four-week period. CoreoGrafts will be implanted in patients needing coronary artery bypass graft ("CABG") surgeries.”
Hancock Jaffe Enrolls Initial Patients for First-in-Human CoreoGraft Study
You can short all u want , I know the charts too well, I know where this going , u about to get short squeezed
HJLI booom volume 11:00est News Alert https://finance.yahoo.com/news/hancock-jaffe-enrolls-initial-patients-150000419.html
Boom!!!
The main stock is on a tear, the warrants should follow right away. If you missed the main run, get in for the warrants run
$HJLIW
Look at $HJLI RUN all of a sudden! The warrants should also run right away as well ... $HJLIW pic.twitter.com/dXVastTKVn
— Eagle Investments (@EagleInvest_) August 25, 2020
When would this occur the merger that is?
Market makers aren’t manipulating the prices. The prices you are seeing are set from traders and active traders. Market makers match prices, now done by computers, and market makers also set the first quote. Don’t believe the bs from posters.
Merger will be milestone for first in class device. Mr. Jenkins has extensive experience in M&A and device product, development. GET READY$$$$$$
Catheter Precision is led by Chairman David Jenkins and CEO Steve Adler. Mr. Jenkins is a seasoned executive and investor who has founded and sold several successful companies to large medical device companies including Baxter, St. Jude Medical, General Electric, and Medtronic. A group led by Mr. Jenkins is expected to make an investment in Hancock Jaffe upon the signing of a definitive merger agreement, and following the closing of the merger transaction
A group led by Mr. Jenkins is expected to make an investment in Hancock Jaffe upon the signing of a definitive merger agreement, and following the closing of the merger transaction.
Mr. Adler has over 35 years of medical device experience including clinical studies, regulatory affairs, sales, and executive management. Over the course of his career, Mr. Adler has been responsible for more than 30 medical devices that have received regulatory approvals, and has led several commercial product launches.
Robert Berman, Hancock Jaffe's CEO stated, "We are excited about the prospect of aligning ourselves with David Jenkins, Steve Adler and their talented team. We believe the proposed merger will be an important first step in creating a diversified medical device company that will appeal to investors and maximize shareholder value.
https://ir.hancockjaffe.com/press-releases/detail/66/hancock-jaffe-announces-intention-to-merge-with-catheter
Couldn't find specifics on the warrants so I really can't be sure fwiw. If your able to get specifics on them I would appreciate it if you could share what you've found. Thanks
If that was the case, the float on the stock would greatly increase but the float on the warrants would greatly decrease. Maybe the warrants will be the ticket to big gains on Monday more than the stock itself
Are you saying the stock will continue to go back down ?
My guess is that they brought the price up to the strike price whereby the warrants could be exercised and them they started dumping to get their monies. That would explain the massive Shares aside from turning over what was available. So in short, theirs dilution to the amounts that are exercised. Might be short lived but it killed the run..
I just want know how a stock could trade over 466 million when there’s only 30 million shares out? Are the institutions short the stock, and is that legal?
When do they expire and what do the warrants provide? Thanks
* * $HJLI Video Chart 08-21-2020 * *
Link to Video - click here to watch the technical chart video
Retrace on the day is .48ish. Will look around there for a quick buy back and flip possibly. It is Friday though..
great news here bud
Positive update on VenoValve patients. This is the kind of news that validates the product so they can sell into a ton more hospitals. It is very good news.
https://finance.yahoo.com/news/hancock-jaffe-announces-one-data-123000676.html
Just curious why is this running
HJLI here's the break!!
Followers
|
17
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
166
|
Created
|
10/24/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |